Sign in
CompletedNo phase

Direct Referral for Apnea Monitoring

Key facts

Who runs it
VA Office of Research and Development
Where
Pittsburgh, Portland, and San Francisco, United StatesSee the 3 sites
Trial code
Status
Completed
People taking part
6,501 people enrolled
Started
1 Aug 2020
Ended
31 Mar 2026
Type of study
Observational, 3 groups
Record updated
13 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Age 18 years Agrees to be seen by a VA sleep program Reason for referral to sleep clinic: New OSA Evaluation

Who cannot take part

  • Age < 18 years Declines to be seen by a VA sleep program Reason for referral to sleep clinic: anything other than a new OSA evaluation

Where in United States

  • VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PAPittsburgh, United States
  • VA Portland Health Care System, Portland, ORPortland, United States
  • San Francisco VA Medical Center, San Francisco, CASan Francisco, United States

About the trial

What the trial wants to find out

The primary objective of this project is to compare a health care delivery model, Direct Referral for Apnea Monitoring (DREAM), with initial in-person (Traditional) clinic appointments for Veterans at risk for obstructive sleep apnea (OSA). A secondary objective is to determine the negative predictive value (NPV) of home sleep apnea testing (HSAT).

The 3 groups in the trial

  • Traditional clinical pathway for OSA

    After referral, patients will have an initial encounter with a sleep care provider which might include in-person visits, telephone clinics, or video conferencing. Intervention/Treatment: Patients in Arm 1 will receive routine care for OSA at one of the participating VA Sleep Medicine clinics.

  • DREAM clinical pathway for OSA

    After referral, patients will not have an initial encounter with a care provider. After a clinician conducts a chart review of medical records, patients in the DREAM pathway will be referred for sleep testing. Intervention/Treatment: Patients in Arm 2 will receive routine care for OSA at one of the participating VA Sleep Medicine clinics.

  • Negative predictive value of HSAT

    Results of sleep tests will be compared for patients who undergo both HSAT and polysomnographic (PSG) procedures. Intervention/Treatment: Patients in Arm 3 will undergo a) HSAT sleep testing followed by PSG testing, or b) simultaneous administration of PSG and HSAT sleep testing.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Improving Access to Sleep Apnea Care: A Pragmatic Study of New Consultation Models
Record updated
13 May 2026